Dr Reddy’s Hyderabad manufacturing plant receives 9 US FDA observations
Dr Reddy’s on October 12 informed the stock exchanges that the US Food & Drug Administration (USFDA) has issued 9 observations for its biologics manufacturing facility at Bachupally in Hyderabad. “The...